RYTELO
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $96,346 | 611 | 411 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,900 | 15 | 45.6% |
| Unspecified | $38,050 | 175 | 39.5% |
| Food and Beverage | $11,251 | 412 | 11.7% |
| Travel and Lodging | $2,165 | 8 | 2.2% |
| Consulting Fee | $980.00 | 1 | 1.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment | Geron Corporation | $20,587 | 0 |
| A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor | Geron Corporation | $9,818 | 0 |
| AN OPEN LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS | Geron Corporation | $7,645 | 0 |
Top Doctors Receiving Payments for RYTELO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Birmingham, AL | $38,050 | 175 |
| , M.D | Internal Medicine | Cleveland, OH | $8,990 | 3 |
| , MD | Hematology & Oncology | Altamonte Springs, FL | $8,313 | 7 |
| , M.D | Hematology | Hackensack, NJ | $8,017 | 4 |
| , M.D | Hematology & Oncology | Cary, NC | $5,336 | 5 |
| , M.D | Hematology | Hackensack, NJ | $5,137 | 3 |
| , M.D | Internal Medicine | Omaha, NE | $4,800 | 1 |
| Bart Scott | Medical Oncology | Seattle, WA | $3,900 | 2 |
| , MD | Medical Oncology | Dallas, TX | $1,600 | 1 |
| , ANP | Nurse Practitioner | Tampa, FL | $980.00 | 1 |
| , M.D | Hematology & Oncology | Pittsburgh, PA | $201.51 | 3 |
| , MD | Hematology & Oncology | Nashville, TN | $150.00 | 1 |
| , M.D | Hematology & Oncology | Nashville, TN | $150.00 | 1 |
| , M.D | Hematology & Oncology | Grand Rapids, MI | $124.45 | 1 |
| , MD | Hematology & Oncology | Ypsilanti, MI | $124.45 | 1 |
| Akriti Jain | Hematology & Oncology | Cleveland, OH | $113.32 | 2 |
| , MD | Diagnostic Radiology | Rockledge, FL | $101.87 | 1 |
| , MD | Diagnostic Radiology | Rockledge, FL | $101.87 | 1 |
| , M.D | Medical Oncology | Palm Bay, FL | $101.87 | 1 |
| , MD | Critical Care Medicine | Melbourne, FL | $101.87 | 1 |
| , M.D., F.A.C.R.O | Therapeutic Radiology | Melbourne, FL | $101.87 | 1 |
| , D.O | Internal Medicine | Cocoa Beach, FL | $101.87 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Titusville, FL | $101.87 | 1 |
| , M.D | Hematology & Oncology | Rockledge, FL | $101.87 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Cleveland, OH | $94.54 | 1 |
Manufacturing Companies
- Geron Corporation $96,346
Product Information
- Type Drug
- Total Payments $96,346
- Total Doctors 411
- Transactions 611
About RYTELO
RYTELO is a drug associated with $96,346 in payments to 411 healthcare providers, recorded across 611 transactions in the CMS Open Payments database. The primary manufacturer is Geron Corporation.
Payment data is available from 2024 to 2024. In 2024, $96,346 was paid across 611 transactions to 411 doctors.
The most common payment nature for RYTELO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,900, 45.6% of total).
RYTELO is associated with 3 research studies, including "A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment" ($20,587).